Expert Perspectives on the Evolving Treatment of EGFR-mutated Advanced and Metastatic NSCLC

Gain in-depth knowledge on the latest data and guideline recommendations to optimize treatment with targeted therapies for patients with EGFR-mutated advanced or metastatic NSCLC in the first-line setting and beyond, through an on-demand webcast with accompanying slides and an expert-authored ClinicalThought commentary.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by educational grants from Boehringer Ingelheim Pharmaceuticals, Inc. and Janssen Biotech, Inc. administered by Janssen Scientific Affairs, LLC.

Boehringer Ingelheim Pharmaceuticals, Inc.

Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC